← back to search

Scott A. Biller

Agios Pharmaceuticals (United States) · US
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Biochemical and Molecular Research, Cancer, Hypoxia, and Metabolism, and Epigenetics and DNA Methylation.
h-index
43
citations
10,388
works
121
NIH funding
primary concept
Chemistry
email

Recent publications

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
Blood Advances 2020cited by 194position: middledoi
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
Nature 2018cited by 280position: middledoi
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Science 2013cited by 1,150position: middledoi
Mutation Selective IDH Inhibitors Mediate Histone and DNA Methylation Changes
Blood 2012cited by 2position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2012–2012) · 1 papers (2012–2012)Sung Choe · NatureServe1 papers (2012–2012)Kimberly Straley · Exicure (United States)1 papers (2012–2012)Katharine Yen · Io Therapeutics (United States)1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012)Michael Su · University of California System1 papers (2012–2012)William G. Kaelin · Harvard University1 papers (2012–2012)Fang Wang · Anhui Provincial Hospital1 papers (2012–2012)Stefan Größ · Agios Pharmaceuticals (United States)1 papers (2012–2012) · 1 papers (2012–2012)Erica Hansen · Agios Pharmaceuticals (United States)1 papers (2012–2012)Stefanie S. Schalm · Blueprint Medicines (United States)1 papers (2012–2012)Lenny Dang · Agios Pharmaceuticals (United States)1 papers (2012–2012)Andrew Kernytsky · University of Tübingen1 papers (2012–2012)Hua Yang · Chongqing University1 papers (2012–2012)Marion Dorsch · Louisiana State University1 papers (2012–2012)Jeremy Travins · Agios Pharmaceuticals (United States)1 papers (2012–2012)